Insider Trading & Ownership - aTYR PHARMA INC (ATYR)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for aTYR PHARMA INC
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-07-22
Purchase
2024-07-24
5:29 pm
aTYR PHARMA INCATYRSCHIMMEL PAUL
Director
100,000$1.8461$184,6131,101,056
(Indirect
Direct)
View
2024-06-05
Purchase
2024-06-06
08:26 am
aTYR PHARMA INCATYRDENYES NANCY
General Counsel
5,000$1.8552$9,27622,267
(Direct)
View
2024-05-30
Purchase
2024-06-03
4:21 pm
aTYR PHARMA INCLIFECOUGHLIN TIMOTHY
Director
50,000$1.75$87,50056,000
(Indirect)
View
2024-05-31
Purchase
2024-06-03
08:38 am
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
5,000$1.79$8,95027,960
(Direct)
View
2024-05-31
Purchase
2024-06-03
08:34 am
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
20,000$1.807$36,140136,548
(Direct)
View
2024-02-06
Sale
2024-02-06
8:18 pm
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
1,590$1.69$2,68728,321
(Direct)
View
2023-12-11
Purchase
2023-12-12
6:50 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$1.1764$17,646106,173
(Direct)
View
2023-11-10
Purchase
2023-11-13
4:11 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$1.1136$16,70391,173
(Direct)
View
2023-07-28
Purchase
2023-08-01
4:07 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$2.0149$30,22476,173
(Direct)
View
2023-05-10
Purchase
2023-05-11
09:00 am
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
200,000$2.25$450,0001,001,056
(Indirect
Direct)
View
2023-02-06
Sale
2023-02-06
7:00 pm
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
1,566$2.36$3,69626,710
(Direct)
View
2022-11-21
Purchase
2022-11-21
9:04 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,000$2.1405$21,40550,798
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-22
Option Award
2024-05-23
7:30 pm
N/A
2034-05-22
aTYR PHARMA INCLIFECLARKE JOHN K
Director
24,000$024,000
(Direct)
View
2024-05-22
Option Award
2024-05-23
7:27 pm
N/A
2034-05-22
aTYR PHARMA INCLIFEGross Jane A
Director
24,000$024,000
(Direct)
View
2024-05-22
Option Award
2024-05-23
7:19 pm
N/A
2034-05-22
aTYR PHARMA INCLIFELucas Svetlana
Director
24,000$024,000
(Direct)
View
2024-05-22
Option Award
2024-05-23
7:16 pm
N/A
2034-05-22
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
24,000$024,000
(Direct)
View
2024-05-22
Option Award
2024-05-23
7:11 pm
N/A
2034-05-22
aTYR PHARMA INCLIFEZaknoen Sara
Director
24,000$024,000
(Direct)
View
2024-05-22
Option Award
2024-05-23
7:07 pm
N/A
2034-05-22
aTYR PHARMA INCLIFECOUGHLIN TIMOTHY
Director
24,000$024,000
(Direct)
View
2024-02-05
Exercise
2024-02-06
8:20 pm
N/A
N/A
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,375$0137,298
(Direct)
View
2024-02-05
Exercise
2024-02-06
8:18 pm
N/A
N/A
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
3,750$028,321
(Direct)
View
2024-02-05
Exercise
2024-02-06
8:15 pm
N/A
N/A
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
2,688$020,141
(Direct)
View
2024-01-05
Option Award
2024-01-09
7:35 pm
N/A
2034-01-05
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
600,000$0600,000
(Direct)
View
2024-01-05
Option Award
2024-01-09
7:33 pm
N/A
2034-01-05
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
150,000$0168,661
(Direct)
View
2024-01-05
Option Award
2024-01-09
7:30 pm
N/A
2034-01-05
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
150,000$0162,079
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:33 pm
N/A
2033-05-17
aTYR PHARMA INCLIFEZaknoen Sara
Director
12,000$012,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:32 pm
N/A
2033-05-17
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
12,000$012,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:30 pm
N/A
2033-05-17
aTYR PHARMA INCLIFELucas Svetlana
Director
12,000$012,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:29 pm
N/A
2033-05-17
aTYR PHARMA INCLIFEGross Jane A
Director
12,000$012,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:27 pm
N/A
2033-05-17
aTYR PHARMA INCLIFECOUGHLIN TIMOTHY
Director
12,000$018,000
(Direct)
View
2023-05-17
Gift
2023-05-19
4:27 pm
N/A
N/A
aTYR PHARMA INCLIFECOUGHLIN TIMOTHY
Director
6,000$018,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:23 pm
N/A
2033-05-17
aTYR PHARMA INCLIFECLARKE JOHN K
Director
12,000$012,000
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:56 pm
N/A
N/A
aTYR PHARMA INCLIFEZaknoen Sara
Director
6,000$06,000
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:54 pm
N/A
N/A
aTYR PHARMA INCLIFECLARKE JOHN K
Director
6,000$019,797
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:54 pm
N/A
N/A
aTYR PHARMA INCLIFESCHIMMEL PAUL
Director
6,000$0801,056
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:53 pm
N/A
N/A
aTYR PHARMA INCLIFELucas Svetlana
Director
6,000$06,000
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:52 pm
N/A
N/A
aTYR PHARMA INCLIFEGross Jane A
Director
6,000$06,000
(Direct)
View
2023-04-26
Exercise
2023-04-28
4:51 pm
N/A
N/A
aTYR PHARMA INCLIFECOUGHLIN TIMOTHY
Director
6,000$06,000
(Direct)
View
2023-02-16
Option Award
2023-02-21
5:08 pm
N/A
2033-02-16
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
336,096$0336,096
(Direct)
View
2023-02-16
Option Award
2023-02-21
5:04 pm
N/A
2033-02-16
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
84,023$084,023
(Direct)
View
2023-02-16
Option Award
2023-02-21
5:00 pm
N/A
2033-02-16
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
84,023$084,023
(Direct)
View
2023-02-03
Exercise
2023-02-06
7:03 pm
N/A
N/A
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
2,688$015,141
(Direct)
View
2023-02-03
Exercise
2023-02-06
7:00 pm
N/A
N/A
aTYR PHARMA INCLIFEBroadfoot Jill Marie
Chief Financial Officer
3,750$026,710
(Direct)
View
2023-02-03
Exercise
2023-02-06
6:57 pm
N/A
N/A
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,375$092,298
(Direct)
View
Goto 0, 1, 2, Next